Cargando…

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

Detalles Bibliográficos
Autores principales: Duret, Pierre-Marie, Sebbag, Eden, Mallick, Auriane, Gravier, Simon, Spielmann, Lionel, Messer, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456545/
https://www.ncbi.nlm.nih.gov/pubmed/32354772
http://dx.doi.org/10.1136/annrheumdis-2020-217362
_version_ 1783575817938272256
author Duret, Pierre-Marie
Sebbag, Eden
Mallick, Auriane
Gravier, Simon
Spielmann, Lionel
Messer, Laurent
author_facet Duret, Pierre-Marie
Sebbag, Eden
Mallick, Auriane
Gravier, Simon
Spielmann, Lionel
Messer, Laurent
author_sort Duret, Pierre-Marie
collection PubMed
description
format Online
Article
Text
id pubmed-7456545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74565452020-09-04 Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept Duret, Pierre-Marie Sebbag, Eden Mallick, Auriane Gravier, Simon Spielmann, Lionel Messer, Laurent Ann Rheum Dis Letter BMJ Publishing Group 2020-09 2020-04-30 /pmc/articles/PMC7456545/ /pubmed/32354772 http://dx.doi.org/10.1136/annrheumdis-2020-217362 Text en © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
spellingShingle Letter
Duret, Pierre-Marie
Sebbag, Eden
Mallick, Auriane
Gravier, Simon
Spielmann, Lionel
Messer, Laurent
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title_full Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title_fullStr Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title_full_unstemmed Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title_short Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
title_sort recovery from covid-19 in a patient with spondyloarthritis treated with tnf-alpha inhibitor etanercept
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456545/
https://www.ncbi.nlm.nih.gov/pubmed/32354772
http://dx.doi.org/10.1136/annrheumdis-2020-217362
work_keys_str_mv AT duretpierremarie recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept
AT sebbageden recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept
AT mallickauriane recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept
AT graviersimon recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept
AT spielmannlionel recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept
AT messerlaurent recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept